NCT06822582 Pelvic Health Rehabilitation After Breast and Gynecologic Cancer
| NCT ID | NCT06822582 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Laval University |
| Condition | Gynecologic Cancers |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-01-07 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-01-07 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The GYVE study aims at testing an online program (eModule) to help people who have had breast or gynecologic cancer and are experiencing pelvic health issues like urinary incontinence and pain during sex. These cancers and their treatments can cause significant pelvic health problems, affecting daily life and quality of life. Physiotherapy can help, but access is often limited due to costs and other barriers. The study will involve 20 participants from Quebec and Edmonton, who will take part in a 12-week program with weekly online group sessions led by a physiotherapist. Topics include pelvic floor muscle training, use of vaginal moisturizers, hydration, diet, and pain management. Led by experts in cancer rehabilitation and pelvic health, the study aims to provide valuable information on the feasibility and effectiveness of the eModule, potentially leading to broader implementation to help more people with lived experience of cancer.
Eligibility Criteria
Inclusion Criteria: * be \>18 years of age; * have received a diagnosis of breast or gynecological (endometrial, cervical, ovarian, vulvar or vaginal) cancer (Stage I-IV) ; * be on active cancer treatment or have completed any cancer treatment (surgery and/or radiation therapy and/or chemotherapy) within the last 3 years; * be able to provide informed written consent in English or French; * have a urogenital dysfunction, as screened by a score of ≥ 2 on the Pelvic Floor Bother Questionnaire. Exclusion Criteria: * do not have regular access to internet, to a smart device or a computer, at home.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06822582 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gynecologic Cancers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06822582 currently recruiting?
Yes, NCT06822582 is actively recruiting participants. Contact the research team at stephanie.bernard@fmed.ulaval.ca for enrollment information.
Where is the NCT06822582 trial being conducted?
This trial is being conducted at Edmonton, Canada, Québec, Canada.
Who is sponsoring the NCT06822582 clinical trial?
NCT06822582 is sponsored by Laval University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.